Expanded hepatitis B reagent range

Hepatitis B is a liver disease caused by the hepatitis B virus. Although a vaccine has been available since 1982, it is estimated that a third of the world’s population has been infected during their lifetime. This infectious disease is still common today in China.

Virostat has expanded its offering of hepatitis B reagents including its Monotope and Omnitope antibodies and recombinant antigens. Specificities include surface antigen (HBsAg), HB core, HB ‘e’, pre-s1, pre-s2 and HB-X. Applications for these reagents include enzyme-linked immunosorbent assay (ELISA), Western blot, immunohistochemistry (IHC) and rapid tests.
www.virostat-inc.com
 

Other news

Learning from history

Upcoming Events

Lab Innovations

NEC, Birmingham (Hall 12)
30-31 October 2019

British Society for Immunology Congress

Arena and Convention Centre, Kings Dock, Liverpool Waterfront, Liverpool L3 4FP
2-5 December 2019

The genomic and molecular revolution in microbiology: in technology we trust (or do we?).

RAF Museum, Hendon, London
14 May 2020

Clinical and Laboratory Haemostasis 2020

STEM/Atrium Conference Centre, Sheffield Hallam University
3-4 June 2020

Latest Issue

Pathology In Practice

Pathology In Practice

Oct 2019

Are you ready for the winter influenza season?

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.